Finally, while the database included a basic myositis antibody panel and several broader autoantibody assays, key cancer-associated antibodies, such as anti-TIF1-γ, anti-NXP2, and anti-SAE, were not available for analysis. This evidence concerns the gene TRIM33 and myositis disease.